Head-to-head comparison of [<sup>11</sup>C]methionine PET, [<sup>11</sup>C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism.

Journal Information

Full Title: Eur J Nucl Med Mol Imaging

Abbreviation: Eur J Nucl Med Mol Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThe study was registered at the Netherlands Trial Register (NTR7423) and approved by the Research Ethics Board of the University Medical Center Groningen, The Netherlands (METc 2018/330). This study was performed in line with the principles of the Declaration of Helsinki. Written informed consent was obtained from all subjects. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research has received funding from the Foundation de Cock-Hadders (project number 2019–51)."

Evidence found in paper:

"The study was registered at the Netherlands Trial Register (NTR7423) and approved by the Research Ethics Board of the University Medical Center Groningen, The Netherlands (METc 2018/330). This study was performed in line with the principles of the Declaration of Helsinki. Written informed consent was obtained from all subjects. Declarations: Ethics approvalThe study was registered at the Netherlands Trial Register (NTR7423) and approved by the Research Ethics Board of the University Medical Center Groningen, The Netherlands (METc 2018/330). This study was performed in line with the principles of the Declaration of Helsinki. Written informed consent was obtained from all subjects.: Competing interestsThe authors declare no competing interests. Ethics approval: The study was registered at the Netherlands Trial Register (NTR7423) and approved by the Research Ethics Board of the University Medical Center Groningen, The Netherlands (METc 2018/330). This study was performed in line with the principles of the Declaration of Helsinki. Written informed consent was obtained from all subjects."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025